Method for administration
AssigneeHoffmann-La Roche Inc.
InventorsKellie Glenn, Brian Higgins, Gwen Nichols, Kathryn Packman
Life of this patent
Estimating the term…
Abstract
There is provided a new dosage regimen for Compound A which maximizes anti-tumor activity while maintaining acceptable toxicity levels.
Claims11
A method of treating a patient suffering form cancer, comprising administering to said patient a pharmaceutical composition containing as an active ingredient Compound A in an amount from about 800 mg/day to about 3000 mg/day, daily, for up to about 7 days, followed by a rest period of up to about 21 days, said administration starting on the first day of a 28 day treatment cycle.
A method of treating a patient suffering form cancer, comprising administering to said patient a pharmaceutical composition containing as an active ingredient Compound A in an amount from about 800 mg/day to about 3000 mg/day, daily, for up to about 5 days, followed by a rest period of up to about 23 days, said administration starting on the first day of a 28 day treatment cycle.
Dependencies are inferred from the claim text.